首页> 外文OA文献 >Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose
【2h】

Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose

机译:估计血液透析中的磷酸盐去除量:量化透析剂量的另一种工具

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Half of the dialysis population suffers from hyperphosphataemia, which is now recognized as a major factor of haemodialysis (HD) morbidity and mortality. Current control is focussed on reducing dietary phosphate intake and diminishing absorption using phosphate binders, whereas control and quantification of phosphate removal by HD is undervalued. The aim of this prospective study was to develop a simple, bedside formula to estimate dialytic phosphate removal in stable HD patients. Methods. This was a prospective, randomized trial. Phosphate and urea elimination were assessed in a representative group of patients at two dialysis centres using randomly different dialysers (1.3-2.4 m2). Quantification was performed by partial dialysate collection, concentration measurements in blood and effluent dialysate spot samples, and Kt/Vurea during standard high‐flux HD. Multiple linear regression analyses were used in 77% of all data sets to generate an equation to predict phosphate removal. The formula was validated in the remaining 23% of data sets, in the same group of patients using a large capillary filter, and in diabetic patients treated with a small dialyser at different blood flows (200, 250, and 300 ml/min). Results. A formula allowing quantification of phosphate removal within one HD session was developed in 18 of 74 patients during 41 treatments (137 out of 177 data sets) and was determined as: MPO4pred=0.1t −17+50cds60+11cb60, where t is treatment time in min, cds60 and cb60 are phosphate concentrations in dialysate and plasma measured 60 min into HD in mmol/l, and MPO4pred is estimated phosphate removed in mmol. The precision was remarkable (r2=0.92-0.94). The comparison of phosphate and Kt/Vurea showed a significant association (r2=0.28), albeit with remarkable scatter. Conclusions. We present the first approach to quantify phosphate removal during high‐flux HD by a bedside formula. Only 28% of the variation in phosphate removal was explained by Kt/Vurea. It appears that other factors not adequately accounted for by Kt/Vurea affect phosphate removal. Therefore, we propose an individual control and quantification of phosphate removal in HD
机译:背景。一半的透析人群患有高磷血症,这已被认为是血液透析(HD)发病率和死亡率的主要因素。当前的控制重点是减少饮食中磷酸盐的摄入并使用磷酸盐粘合剂减少吸收,而对通过高清进行的磷酸盐去除的控制和量化却被低估了。这项前瞻性研究的目的是开发一种简单的床边配方,以评估稳定的HD患者透析液中磷酸盐的去除率。方法。这是一项前瞻性随机试验。在两个透析中心的一组代表性患者中,使用随机不同的透析器(1.3-2.4μm2)评估了磷酸盐和尿素的消除。通过部分透析液收集,血液和污水透析液现场样品中的浓度测量以及标准高通量HD期间的Kt / Vurea进行定量。在所有数据集中的77%中使用了多个线性回归分析,以生成方程式来预测磷酸盐的去除。该公式已在其余23%的数据集中,使用大型毛细管过滤器的同一组患者以及在不同血流量(200、250和300μml/ min)下用小型透析仪治疗的糖尿病患者中得到了验证。结果。在41次治疗中,有74位患者中的18位(177个数据集中的137个)开发了一个公式,可以量化一次HD阶段的磷酸盐去除量,其公式为:MPO4pred = 0.1t -17 + 50cds60 + 11cb60,其中t为治疗时间以分钟为单位,cds60和cb60是透析液和血浆中血浆中磷酸盐的浓度,以mmol / l为单位,在60分钟内测量到HD,而MPO4pred估计以mmol为单位除去了磷酸盐。精度非常好(r2 = 0.92-0.94)。磷酸盐和Kt / Vurea的比较显示出显着的相关性(r2 = 0.28),尽管具有显着的分散性。结论。我们提出了第一种通过床头公式量化高通量高清过程中磷酸盐去除的方法。 Kt / Vurea解释了磷酸盐去除率中只有28%的变化。看来,Kt / Vurea未充分说明的其他因素会影响磷酸盐的去除。因此,我们建议对高清中的磷酸盐去除进行单独控制和定量

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号